Pittsburgh, PA · Founded 2013 · Privately Held (backing)
Developer of a therapeutic and drug discovery peptide platform designed to treat multidrug-resistant bacterial infections. Peptilogics is based in Pittsburgh, PA and was founded in 2013. It was valued at $150 million at its later-stage round in May 2025, the last priced event on record. It has raised $195 million across 4 recorded rounds; the latest was a $35.8 million early-stage round in Dec 2020.
PMV mark · valuation
$150.0M
Oct 2026
Priced at
its later-stage round
May 2025
Total raised
$194.8M
Last round
Early Stage VC
Dec 2020
Team — not yet on record
No current team members for Peptilogics are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Peptilogics with a free account
·The complete investor list: 30 names
·Watch Peptilogics: the Monday email on marks, rounds and moves
